At the end of August each year the Exchange reviews the KVX Growth Market, and a company will only remain in the KVX Index provided that:
- The company's average market capitalisation during the last 12 months has not been under DKK 300 million
- The average daily turnover in the company's shares on the Copenhagen Stock Exchange over the last 12 months has exceeded DKK 500,000.
Companies that are placed in the KVX Growth Market must still fulfil the same disclosure requirements etc. which apply to all other listed companies.
Changes in the KVX Growth Market
Companies already listed may currently be transferred to the KVX Growth Market. EDB Gruppen meets the criteria for the KVX Growth Market, and the company will be transferred to the KVX Growth Market in connection with the review.
Columbus IT Partner will be transferred to the Exchange's main market, as the company has not met the criteria of quantity to remain in the KVX Growth Market.
The KVX Growth Market as from 1 September 2001
- 2M Invest
- Bavarian Nordic
- Danionics
- Danware
- EDB Gruppen
- Genmab
- i-data international
- Maconomy
- NeuroSearch
- Pharmexa
- RTX Telecom
- Simcorp
- Thrane & Thrane
In continuation of the annual review of the KVX Index, the Copenhagen Stock Exchange has used the opportunity to review the guidelines on the inclusion of companies in the KVX Growth Market. The review has resulted in the following changes:
- The KVX companies' affiliation to an industry has been expanded. This means that a KVX company must either operate within telecommunications, information technology, pharmaceuticals and biotechnology or must primarily invest within these or corresponding growth industries.
- The criteria of an expected annual growth rate of at least 20 per cent has been taken out.